MedPath

吉林万通药业集团梅河药业股份有限公司

Ownership
-
Established
2001-10-18
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

94

NMPA:94

Drug Approvals

复方石斛片

Approval Number
国药准字Z20063400
Approval Date
Sep 4, 2020
NMPA

苦参片

Approval Number
国药准字Z20133017
Approval Date
Sep 4, 2020
NMPA

Erythromycin Estolate Granules

Product Name
依托红霉素颗粒
Approval Number
国药准字H34022668
Approval Date
Aug 17, 2020
NMPA

消风止痛宁

Approval Number
国药准字Z22025186
Approval Date
Jul 24, 2020
NMPA

安胃胶囊

Approval Number
国药准字Z22021802
Approval Date
Jul 24, 2020
NMPA

羚竺散

Approval Number
国药准字Z20054186
Approval Date
Jul 24, 2020
NMPA

刺五加片

Approval Number
国药准字Z22025159
Approval Date
Jul 24, 2020
NMPA

妇科调经片

Approval Number
国药准字Z22025195
Approval Date
Jul 24, 2020
NMPA

降糖宁胶囊

Approval Number
国药准字Z22021512
Approval Date
Jul 24, 2020
NMPA

复方丹参片

Approval Number
国药准字Z22025193
Approval Date
Jul 24, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 10
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.